Design Therapeutics, Inc.
DSGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807120
No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Design Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 52
- +2 vs. Q2 2021
- Shares held
- 28.3M
- +442.2K (+1.6%) vs. Q2 2021
- Total value
- $414.8M
- −$131.4M (−24.1%) vs. Q2 2021
- New holders
- 3
- 23 more added
- Sold out
- 1
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DSGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 136 | $626.4M |
| Q1 2026 | 125 | $404.1M |
| Q4 2025 | 117 | $357.6M |
| Q3 2025 | 95 | $259.7M |
| Q2 2025 | 93 | $116.4M |
| Q1 2025 | 98 | $133.0M |
| Q4 2024 | 95 | $206.5M |
| Q3 2024 | 100 | $172.3M |
| Q2 2024 | 95 | $107.5M |
| Q1 2024 | 93 | $123.9M |
| Q4 2023 | 88 | $84.0M |
| Q3 2023 | 87 | $77.6M |
| Q2 2023 | 97 | $244.4M |
| Q1 2023 | 96 | $223.3M |
| Q4 2022 | 83 | $414.2M |
| Q3 2022 | 79 | $667.2M |
| Q2 2022 | 74 | $541.7M |
| Q1 2022 | 63 | $613.7M |
| Q4 2021 | 60 | $773.1M |
| Q3 2021 | 52 | $414.8M |
| Q2 2021 | 50 | $546.2M |
| Q1 2021 | 43 | $755.2M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Design Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State of Wyoming | 81 | $1.00K | 0.00% | −40−33.1% | Reduced |
| Advisor Group Holdings, Inc. | 96 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 446 | $7.00K | 0.00% | −1,683−79.1% | Reduced |
| Ameritas Investment Partners, Inc. | 1,057 | $16.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,134 | $17.0K | 0.00% | +636+127.7% | Added |
| Legal & General Group Plc | 1,276 | $19.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,590 | $23.0K | 0.00% | +668+72.5% | Added |
| STRS Ohio | 2,000 | $29.0K | 0.00% | −1,100−35.5% | Reduced |
| Piper Sandler & Co. | 2,500 | $37.0K | 0.05% | +2,500 | New |
| California State Teachers Retirement System | 7,242 | $106.0K | 0.00% | −11,357−61.1% | Reduced |
| Morgan Stanley | 7,404 | $108.0K | 0.00% | +6,757+1,044.4% | Added |
| American International Group, Inc. | 7,623 | $112.0K | 0.00% | +72+1.0% | Added |
| Deutsche Bank AG | 8,015 | $118.0K | 0.00% | +15+0.2% | Added |
| JPMorgan Chase & Co | 8,137 | $120.0K | 0.00% | +142+1.8% | Added |
| Rhumbline Advisers | 10,589 | $156.0K | 0.00% | +10,589 | New |
| New York State Common Retirement Fund | 11,738 | $172.0K | 0.00% | +138+1.2% | Added |
| Millennium Management LLC | 14,169 | $208.0K | 0.00% | +14,169 | New |
| Octagon Capital Advisors LP | 14,926 | $219.0K | 0.05% | −235,074−94.0% | Reduced |
| State of Wisconsin Investment Board | 17,400 | $256.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 24,808 | $364.0K | 0.00% | +1,118+4.7% | Added |
| Bank of America Corp | 31,630 | $465.0K | 0.00% | +25,228+394.1% | Added |
| Bank of New York Mellon Corp | 36,476 | $536.0K | 0.00% | +2,979+8.9% | Added |
| Nuveen Asset Management, LLC | 43,045 | $696.0K | 0.00% | −468−1.1% | Reduced |
| Ensign Peak Advisors, Inc | 50,000 | $735.0K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 55,134 | $810.0K | 0.00% | +34,056+161.6% | Added |
| TD Asset Management Inc | 65,718 | $965.0K | 0.00% | +44,396+208.2% | Added |
| Charles Schwab Investment Management Inc | 90,521 | $1.33M | 0.00% | +2,756+3.1% | Added |
| Northern Trust Corp | 122,832 | $1.80M | 0.00% | −12,695−9.4% | Reduced |
| Adage Capital Partners GP, L.L.C. | 165,000 | $2.42M | 0.00% | +119,888+265.8% | Added |
| Norges Bank | 200,000 | $2.94M | 0.00% | 00.0% | Unchanged |
| State Street Corp | 211,608 | $3.11M | 0.00% | +23,519+12.5% | Added |
| Principal Financial Group Inc | 220,510 | $3.24M | 0.00% | +9,008+4.3% | Added |
| Credit Suisse AG | 235,938 | $3.47M | 0.00% | −4,220−1.8% | Reduced |
| Geode Capital Management, LLC | 258,032 | $3.79M | 0.00% | +5,272+2.1% | Added |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 280,991 | $4.13M | 0.05% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 334,050 | $4.91M | 0.10% | +2,000+0.6% | Added |
| Artal Group S.A. | 400,000 | $5.88M | 0.14% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 400,000 | $5.88M | 0.08% | 00.0% | Unchanged |
| Vivo Capital, LLC | 530,991 | $7.80M | 0.35% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 936,659 | $13.1M | 0.01% | +90.0% | Added |
| Wellington Management Group LLP | 955,588 | $14.0M | 0.00% | +16,226+1.7% | Added |
| FMR LLC | 1,000,000 | $14.7M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,088,201 | $16.0M | 0.00% | −117,765−9.8% | Reduced |
| BlackRock Inc. | 1,312,664 | $19.3M | 0.00% | −90,678−6.5% | Reduced |
| Baker Bros. Advisors LP | 1,436,636 | $21.1M | 0.09% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 1,448,968 | $21.3M | 0.00% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 1,468,318 | $21.6M | 0.34% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 1,863,098 | $27.4M | 0.97% | +603,079+47.9% | Added |
| Ra Capital Management, L.P. | 2,186,636 | $32.1M | 0.45% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,572,530 | $37.8M | 0.04% | +6,382+0.2% | Added |
| Logos Global Management LP | 2,772,501 | $40.7M | 2.94% | +40,000+1.5% | Added |
| Cormorant Asset Management, LP | 5,364,850 | $78.8M | 3.20% | −50,000−0.9% | Reduced |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −4,338−100.0% | Sold out |